TCMH upgrades to Level III STEMI designation

Texas County Memorial Hospital recently received Level III STEMI designation from the Missouri Department of Health and ...
The Indianapolis Star

Aspire Biopharma Announces Breakthrough Final Results from Clinical Trial of Investigational New Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial ...

Aspire’s sublingual aspirin formulation significantly inhibited serum thromboxane B2 (TxB2) within the first two minutes after dosing TxB2 is a biomarker indicating aspirin’s effect on platelet ...
Nasdaq

New Analysis Reveals Icosapent Ethyl Significantly Reduces Risk of Major Cardiovascular Events in Patients with Prior Myocardial Infarction (Heart Attack)

The latest prespecified and post hoc sub-analysis of the landmark REDUCE-IT® study, published today in the Journal of the American College of Cardiology (JACC), demonstrated that VASCEPA® (icosapent ...
Healio

AI-based ECG model linked to reduction in false positives for heart attack

Please provide your email address to receive an email when new articles are posted on . An AI-based ECG model more accurately diagnosed a type of heart attack compared with standard of care. The ...